Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Freeze-dried strawberry powder is a dietary intervention and nutraceutical being investigated by researchers at the University of Nevada, Las Vegas (UNLV) for its potential to improve cardiometabolic health. The intervention typically involves a daily dose of 32 grams of the powder, which is equivalent to approximately 2.5 servings of fresh strawberries. It is rich in bioactive compounds, including polyphenolic flavonoids such as anthocyanins and ellagic acid, as well as dietary fiber, phytosterols, and carotenoids. The powder is studied for its ability to reduce oxidative stress, enhance antioxidant enzyme systems, and lower systemic inflammatory markers. Clinical research, such as the 'Strawberries and Risk of Diabetes in Adults' trial (NCT05362968), has focused on its effects on glycemic control, insulin resistance, and HbA1c levels in adults with prediabetes and metabolic syndrome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on freeze-dried strawberry powder.